Israel has begun testing a coroanvirus vaccine prototype at a bio-chemical defence laboratory

 FIRSTPOST.

APRIL 01, 2020



Israel has begun testing a COVID-19 vaccine prototype on rodents at its bio-chemical defence laboratory, a source said on Tuesday.
Prime Minister Benjamin Netanyahu ordered the Israel Institute for Biological Research (IIBR), in rural Ness Ziona, to join the fight against the coronavirus pandemic on 1 February, prompting an easing of its secrecy as it cooperates with civilian scientists and private firms.
In a statement, Netanyahu’s office said IIBR director Shmuel Shapira had informed him of “significant progress” in designing a vaccine prototype and that the institute “is now preparing a model for commencing an animal trial”.
A source familiar with IIBR activities told Reuters that trials were already underway on rodents. The source declined to identify the kind of rodent.
The IIBR is widely assumed to have worked on biological and chemical arms projects. Israel neither confirms nor denies this.
In rare public comments, IIBR chief innovation officer Eran Zahavy said last week that the institute had shifted its entire focus to the new coronavirus, with three groups trying to develop a vaccine against the COVID-19 disease it causes, and others researching potential treatments.
“We are trying as much as we can to collaborate and have other ideas of other people,” he said at last week’s English-language online conference hosted by Jerusalem Venture Partners.
“But the facility of the lab is very crowded and very busy and very dangerous so it has to be very slow and very cautious.”
Israel has reported 4,473 cases of COVID-19 and 17 fatalities. Having tightened restrictions on public movement, Netanyahu is weighing a lockdown of parts of the country.
Both Netanyahu and the chief of Israel’s military, Lieutenant-General Aviv Kohavi, went into self-isolation this week after being exposed to coronavirus carriers. Netanyahu tested negative for the virus on Monday. Test results for Kohavi are pending, the military said.
Zahavy described arranging an animal test-subject as “a very big challenge” because “this disease is not affecting animals”.
“It’s not enough only to detect neutralizing antibodies in the animal. You really want to see them getting sick and getting better by this vaccine,” he said.
The IIBR has a “unique animal” for such tests, he said, as well as “a very unique technology to detect animals - even if they are not really sick - to follow them and see their interaction with the disease”. He did not elaborate.
The IIBR is also involved in plasma collection from people who have recovered from infection with the new coronavirus, in the hope that this might help research.
Israeli Defense Minister Naftali Bennett said the IIBR was sampling several COVID-19 testing kits on offer before the country orders them en masse.


Reference link: https://www.firstpost.com/health/israel-has-begun-testing-a-coroanvirus-vaccine-prototype-at-a-bio-chemical-defence-laboratory-8213371.html

Comments

Post a Comment

Popular posts from this blog

Pakistan's shame: 139 Pakistanis on UN terror list; Hafiz Saeed also named

Business Standard April 05, 2018 Amid its apparent failure to withdraw support and funding to proscribed terrorist organisations, Pakistan is set to be 'grey listed' by the Financial Action Task Force in June. Pakistan continues to be associated with globally-censured terrorists with 139 Pakistani citizens and entities featuring in the United Nations Security Council's (UNSC's) consolidated list of terrorists or terror-supporting organisations. The individuals and entities from the country in the list include Mumbai terrorist attack mastermind Hafeez Saeed's outfit Lashkar-e-Taiba, mafia don Dawood Ibrahim Kaskar and the Haqqanis. The list was released on Tuesday and highlighted names of terrorists who lived in Pakistan, used Pakistani soil for their operations or collaborated with terrorist groups operating from within Pakistan. The list is topped by Osama bin Laden's heir apparent Ayman al-Zawahiri, who was a former operational and military lea...
Read more
 The Telegraph  December 24, 2020 A new, potentially more infectious variant of the novel coronavirus that causes Covid-19 has been found in Britain in cases linked to South Africa, British health secretary Matt Hancock said on Wednesday.  South Africa’s health department said last week that a new genetic mutation of the virus had been discovered and might be responsible for a recent surge in infections there. “Thanks to the impressive genomic capability of the South Africans, we’ve detected two cases of another new variant of coronavirus here in the UK,” Hancock told a media briefing. “Both are contacts of cases who have travelled from South Africa over the past few weeks.”  Britain is already trying to curb the spread of a mutated strain of the virus which is up to 70 per cent more transmissible, and further studies are being carried out on the new variant. “This new variant is highly concerning, because it is yet more transmissible, and it appears to have mutated ...
Read more

CIBIL- SIDBI study: ‘Despite rate cuts & govt push, MSME credit growth slides’

The Indian Express October 17, 2019 Mirroring the deepening slowdown in the economy, commercial lending exposure in the country has declined 2.6 per cent, or Rs 1,70,000 crore, to Rs 63.8 lakh crore in the June quarter of 2019-20 from Rs 65.5 lakh crore in March 2019, said a TransUnion CIBIL- SIDBI study. Despite several rate cuts by the RBI, micro, small and medium enterprises (MSMEs) have recorded a slide in credit exposure. “Entities having less than Rs 25 crore credit exposure have reported a lower credit growth rate of 12 per cent in the year ended June 2019 as against a growth rate of 23.1 per cent last year. Very small segment (less than Rs 10 lakh exposure) have registered a credit growth of only 11.3 per cent in June as against a growth rate of 26.2 per cent last year,” says the study. Of the Rs 63.8-lakh crore commercial lending exposure, micro and SME segments account for Rs 15.7 lakh crore exposure (24.5 per cent of commercial credit outstanding). While mi...
Read more